Sponsor hub
Albert Einstein College of Medicine clinical trial failures
Review 26 stopped clinical trials from Albert Einstein College of Medicine, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 0 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 20
- OTHER/UNKNOWN
- 6
Notable sponsors
- Albert Einstein College of Medicine
- 26
Related phases
- Phase II
- 10
- Phase I
- 5
- Unknown
- 5
- Phase III
- 3
- Phase IV
- 2
Crawlable stopped-trial records
Open ExploreShowing up to 26 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Diabetes Mellitus trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Protocol was terminated due to enrollment + feasibility issues. Aim 2 not conducted. Aims 1 + 3 were conducted in part. During Aim 3 the IRB requested that the study be transitioned under a new protocol (2018-9208) in order to simplify reporting.
Phase IV Diabetes Mellitus, Type 1 trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Study suspended for a prolonged duration due to the Pandemic. Once research resumed project was streamlined due to insufficient resources. Study was sufficiently powered to conduct analysis for 2 of the arms. Remaining Aims were never initiated.
Unknown Stage IIA Breast Cancer trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Interventional component of study terminated prior to full enrollment
Phase II Metastatic dMMR Solid Cancer trial by Albert Einstein College of Medicine. Stop reason: OTHER/UNKNOWN.
Following discussion with the Cancer Center the PI elected to terminate the study.
Phase II Pancreatic Cancer trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Slow accrual
Phase I Type 2 Diabetes trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Per source documents the study was terminated well in advance of targeted enrollment. A method for the analysis of insulin and proinsulin samples was never fully developed and validated. Study terminated upon expiration of IRB approval
Phase I Non Small Cell Lung Cancer trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Low accrual
Phase III Pancreatic Cancer trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Study administratively closed out by the Einstein IRB. NO US enrolling sites.
Phase II Pancreatic Adenocarcinoma trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Study was terminated due to slower than anticipated accrual
Phase III Strongyloides Stercoralis Infection trial by Albert Einstein College of Medicine. Stop reason: OTHER/UNKNOWN.
The original study PI passed away. Primary and Study Completion dates revised to reflect last participant examination date.
Phase II Chemotherapy-induced Nausea and Vomiting trial by Albert Einstein College of Medicine. Stop reason: OTHER/UNKNOWN.
Expired IRB approval on 2/11/21
Phase II Endometrial Adenocarcinoma trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Due to slow accrual. Results from the PORTEC3 the study rendered the hypothesis no longer valid.
Phase II Endometrial Serous Adenocarcinoma trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Low accrual. Study formally terminated by PI on 12/1/2017
Unknown Stage IA Uterine Sarcoma trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Lack of accrual. PI left the institution
Unknown Stage IA Uterine Sarcoma trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Study terminated due to low accrual. PI left the institution
Early Phase I HLA-A2 Positive Cells Present trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Due to lack of accrual the study was formally terminated on 01-JUL-2020. Primary Completion and Study Completion Dates have been revised based accordingly based on respective definitions
Phase II Diabetes Mellitus, Type 2 trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Permanently terminated due to COVID-19 given the poor vaccine penetrance in liver transplant recipients. This is not a suspension of IRB approval.
Unknown DS (Durie/Salmon) Stage I Plasma Cell Myeloma trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
The study was stopped during the interim analysis due to low accrual after the widespread use of plerixafor for multiple myeloma in the United States.
Phase I Osteosarcoma trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Study withdrawn before any participants could be enrolled. Issues being able to effectively recruit participants into the study.
Phase III Intraventricular Hemorrhage of Prematurity trial by Albert Einstein College of Medicine. Stop reason: OTHER/UNKNOWN.
Closed by PI prior to approval
Phase II Pain trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Never started the study cause of the lack of funding
Phase II Stage IIIA Non-Small Cell Lung Cancer trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
low accrual
Phase I Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
Low accrual
Phase I Adult B Acute Lymphoblastic Leukemia trial by Albert Einstein College of Medicine. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Pulmonary Embolism trial by Albert Einstein College of Medicine. Stop reason: OTHER/UNKNOWN.
Study did not receive IRB approval, so did not start
Unknown Basal Cell Carcinoma of the Skin trial by Albert Einstein College of Medicine. Stop reason: OPERATIONAL.
no enrollment